First Light Biosciences Develops a Novel Method for Rapidly Determining Effective Antibiotics for Treating Infections
First Light Biosciences, a provider of innovative diagnostic tests for fighting life-threatening in…
First Light Biosciences, a provider of innovative diagnostic tests for fighting life-threatening in…
A test that may reduce, from days to hours, the time needed to diagnose patients with bacterial inf…
As Part of national efforts to improve the diagnosis of tuberculosis (TB), the Minister of Health, …
OpGen, Inc. announced a groundbreaking collaboration with the New York State Department of Health…
Global pharmaceutical company Mylan N.V. and medical device company Atomo Diagnostics today announc…
In a potential game changer for the health care industry, a new cell phone app and lab kit now allo…
Cepheid announced the CE-IVD marking of Xpert HCV VL Fingerstick, the first molecular test to detec…
About 40 percent of clinically abnormal milk samples tested with traditional bacterial culture come…
QIAGEN N.V. and NeuMoDx Molecular, Inc. announced a strategic partnership to commercialize two new …
A £3 million interdisciplinary research project is to address the growing threat of drug-resistant …
IDEXX Laboratories, Inc., the global leader in rapid microbiological testing for water, today annou…
Curetis N.V., a developer of next-level molecular diagnostic solutions, today announced that its wh…
As part of its Horizon 2020 research and innovation program, the European Union has agreed to suppo…
Quidel, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecu…